Leni von Bonsdorff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Leni von Bonsdorff has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Enni Lindeberg
Finnish Red Cross Blood Transfusion Service, Kivihaantie 7, FIN-00310 Helsinki, Finland
1 shared publicationJaakko Parkkinen
Finnish Red Cross Blood Transfusion Service, Kivihaantie 7, FIN-00310 Helsinki, Finland
1 shared publicationJari Lehto
Department of Public Health, PO Box 41, University of Helsinki, FIN-00014 Helsinki, Finland
1 shared publicationLeila Sahlstedt
Department of Medicine, PO Box 340, Helsinki University Central Hospital, FIN-00029 Helsinki, Finland
1 shared publication
Latest Publications
- Open Access
- 1 February 2002
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 48 (2) , 307-314
Bleomycin-detectable Iron Assay for Non-Transferrin-bound Iron in Hematologic Malignancies
Background: A microwell modification of the bleomycin assay for determining non-transferrin-bound iron (NTBI) was evaluated and compared with a chelation method. Methods: The bleomycin assay reagent and sample volumes were halved, and measurements were done in microwell plates. Samples from patients treated for hematologic malignancies were studied. The chelation method was based on mobilization of NTBI with a chelator and measurement of the ultrafiltered iron-chelator complex. NTBI results were also compared with transferrin saturation and the distribution of transferrin iron forms by urea-polyacrylamide gel electrophoresis. Results: The bleomycin assay intraassay imprecision (CV) was 7.7% and 8.2% and the interassay imprecision was 18% and 9.8% for a low (0.2 μmol/L) and a high (1.5 μmol/L) control, respectively. Hemolysis increased measured NTBI. A detection limit of 0.1 μmol/L was established based on the interference of nonvisible hemolysis and on accuracy studies. In patient samples, NTBI exceeded the detection limits only when transferrin saturation was >80%. Compared with the chelation method, the bleomycin assay gave clearly lower NTBI concentrations. The chelation method also gave positive results at 80%, suggesting high specificity. Bleomycin-detectable iron constitutes only a portion of the NTBI measured by the chelation method.
- 1 February 2002
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 48 (2) , 307-314
Open AccessBleomycin-detectable Iron Assay for Non-Transferrin-bound Iron in Hematologic Malignancies
Background: A microwell modification of the bleomycin assay for determining non-transferrin-bound iron (NTBI) was evaluated and compared with a chelation method. Methods: The bleomycin assay reagent and sample volumes were halved, and measurements were done in microwell plates. Samples from patients treated for hematologic malignancies were studied. The chelation method was based on mobilization of NTBI with a chelator and measurement of the ultrafiltered iron-chelator complex. NTBI results were also compared with transferrin saturation and the distribution of transferrin iron forms by urea-polyacrylamide gel electrophoresis. Results: The bleomycin assay intraassay imprecision (CV) was 7.7% and 8.2% and the interassay imprecision was 18% and 9.8% for a low (0.2 μmol/L) and a high (1.5 μmol/L) control, respectively. Hemolysis increased measured NTBI. A detection limit of 0.1 μmol/L was established based on the interference of nonvisible hemolysis and on accuracy studies. In patient samples, NTBI exceeded the detection limits only when transferrin saturation was >80%. Compared with the chelation method, the bleomycin assay gave clearly lower NTBI concentrations. The chelation method also gave positive results at 80%, suggesting high specificity. Bleomycin-detectable iron constitutes only a portion of the NTBI measured by the chelation method.